Previous Article in Journal
5-Aminolevulinic Acid-Mediated Photodynamic Therapy Induces Ferroptosis in Oral Leukoplakia and Oral Squamous Cell Carcinoma
Previous Article in Special Issue
Natural Deep Eutectic Solvent (NaDES) Extraction, HPLC-DAD Analysis, and Antioxidant Activity of Chilean Ugni molinae Turcz. Fruits
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 15
Issue 2
10.3390/antiox15020169
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Bioactive Components of Parthenocissus quinquefolia with Antioxidant and Anti-Inflammatory Properties: A Systematic Review

by
Álvaro Becerra
1,
Felipe Soto
1,
Alejandro Vallejos
1,
Daniela Millán
2,
Juan José Valenzuela-Fuenzalida
3,
Jose E. Leon-Rojas
4,* and
Manuel E. Cortés
5
1
Escuela de Fonoaudiología & Departamento de Ciencias Químicas y Biológicas, Facultad de Ciencias de la Salud, Universidad Bernardo O’Higgins, Santiago 8370854, Chile
2
Escuela de Nutrición y Dietética & Centro Integrativo de Biología y Química Aplicada (CIBQA), Facultad de Salud, Universidad Bernardo O’Higgins, Santiago 8370854, Chile
3
Departamento de Morfología, Facultad de Medicina, Universidad Andrés Bello, Santiago 8370146, Chile
4
Grupo de Investigación Bienestar, Salud y Sociedad, Escuela de Psicologia y Educación, Universidad de Las Américas, Quito 170124, Ecuador
5
Dirección de Investigación, Vicerrectoría Académica, Universidad Bernardo O’Higgins, Santiago 8370854, Chile
*
Author to whom correspondence should be addressed.
Antioxidants 2026, 15(2), 169; https://doi.org/10.3390/antiox15020169
Submission received: 31 December 2025 / Revised: 20 January 2026 / Accepted: 21 January 2026 / Published: 27 January 2026
(This article belongs to the Special Issue Antioxidant Research in Chile—2nd Edition)
Browse Figures
Review Reports Versions Notes

Abstract

Background: Parthenocissus quinquefolia (Virginia creeper), widely distributed and used in Chile, lacks a systematic characterization of its bioactive components. This study synthesizes the evidence on the phytochemical composition and biological activities of P. quinquefolia, with emphasis on metabolites involved in redox regulation and inflammation. Methods: A systematic review was conducted following PRISMA 2020 guidelines. Searches were performed across four electronic databases, including original studies reporting antioxidant and anti-inflammatory effects. Results: Of 665 records identified, 14 studies met the inclusion criteria. Phytochemical analyses revealed phenolic compounds, particularly flavonoids (e.g., catechin, epicatechin, gallocatechin, epigallocatechin, quercetin, rutin, isoquercitrin, myricetin, luteolin, naringin) and stilbenes (e.g., ε-viniferin, miyabenol C). These metabolites exhibit antioxidant activity through ROS scavenging, metal chelation, and Nrf2/ARE activation. Anti-inflammatory effects were attributed to the downregulation of NF-κB, AP-1, and MAPK signaling, inhibition of NLRP3 inflammasome activation, and suppression of COX-2/iNOS expression. Conclusions: P. quinquefolia is a rich source of phenolic metabolites with robust antioxidant and anti-inflammatory mechanisms. The consistency of molecular responses across studies highlights its potential as a promising candidate for phytotherapeutic development targeting oxidative stress and inflammatory pathways.

1. Introduction

Parthenocissus quinquefolia (L.) Planch., commonly known as Virginia creeper, is a member of the Vitaceae family and is indigenous to North America; however, it is now cultivated and distributed worldwide, including in Chile through horticultural nurseries and ornamental landscaping projects [1,2]. Although P. quinquefolia is exotic to the Southern Cone, recent interest in introduced ornamental and medicinal plants in Chile alongside ongoing research into native species with antioxidant potential (e.g., Aristotelia chilensis, Berberis microphylla, Peumus boldus) [3,4] suggests that P. quinquefolia may represent a complementary phytochemical resource. Its local availability further enhances its potential for phytochemical research and future biotechnological applications. Historically, P. quinquefolia has been used by Native American populations for a wide range of medicinal purposes, including treatments for inflammatory conditions, metabolic disorders, and infectious processes [5]. More recently, experimental studies have reported antioxidant, anti-inflammatory, metabolic, antimicrobial, and anticancer properties associated with extracts obtained from different plant organs [6,7,8,9,10,11]. Collectively, these findings suggest potential protective effects against cancer progression, as well as antibacterial, antiviral, antidiabetic, antirheumatic, hypocholesterolemic, gastrointestinal, and diuretic activities. Collectively, these findings suggest potential protective effects against cancer progression, as well as antibacterial, antiviral, antidiabetic, antirheumatic, hypocholesterolemic, gastrointestinal, and diuretic activities. These biological properties are largely attributed to the presence of secondary metabolites bioactive compounds synthesized by plants in response to biotic and abiotic stimuli, enabling adaptation to environmental stressors [12]. These compounds are widely utilized in the pharmaceutical, cosmetic, nutraceutical, food, and agrochemical industries [13,14,15]. Consequently, the ethnobotanical and pharmacological characterization of introduced and native species has become increasingly relevant for identifying compounds with biomedical applications.
Given that many of these biological activities are mechanistically linked to redox imbalance and immune modulation, it is pertinent to consider the role of inflammation in this context. Inflammation represents a complex biological response to cellular and tissue injury caused by pathogens (e.g., viruses, bacteria, fungi), chemical irritants, physical agents, or dysregulated immune activity. When unresolved, inflammation may become chronic, promoting oxidative stress, cellular damage, and molecular remodeling associated with carcinogenesis, accelerated aging, metabolic disease, and increased mortality [16,17]. Considerable evidence has demonstrated that secondary metabolites exert antioxidant and anti-inflammatory effects through redox modulation, reactive oxygen species (ROS) scavenging, mitochondrial protection, and regulation of pro-inflammatory signaling pathways such as NF-κB, COX-2, and iNOS [18,19,20,21]. The abundance of phenolic compounds with antioxidant and anti-inflammatory properties reported in P. quinquefolia suggests that this species may contribute to the identification of novel therapeutic targets. Therefore, the objective of this systematic review is to summarize the available evidence regarding the composition, distribution, and biological effects of secondary metabolites with anti-inflammatory potential isolated from or identified in P. quinquefolia.
The abundance of compounds with antioxidant and anti-inflammatory properties in P. quinquefolia suggest its potential for the identification of novel therapeutic targets. The objective of this review is to provide an overview of the reported composition, distribution, and biological effects of secondary metabolites with anti-inflammatory properties in P. quinquefolia.
Representative structures of phenolic metabolites identified in P. quinquefolia are shown in Figure 1 to illustrate the chemical diversity of flavonoids and stilbenoids present in the species.

2. Materials and Methods

2.1. Method Designs

This study was guided by the checklist of proposed elements according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 [22]. The registration DOI in Open Science Framework (OSF) is https://osf.io/hx8nw (Accessed 4 January 2026).

2.2. Selection Criteria

Studies eligible for inclusion are original research articles that provide information on the anti-inflammatory or antioxidant effects, as well as other beneficial health effects, of the plant species P. quinquefolia, or any of its other names mentioned in the search terms (Ampelopsis quinquefolia, Hedera quinquefolia, Vitis quinquefolia, Virginia creeper), published in English.

2.3. Information Source and Search Strategies

A systematic search was conducted in PubMed, Scopus, Web of Science, and Google Scholar from inception to May 2025. Additional records were identified through reference screening. No publication date restrictions were applied. Language was restricted to English and only original research articles were eligible. The following Boolean search strategy was used: (“Parthenocissus quinquefolia” OR “Ampelopsis quinquefolia” OR “Hedera quinquefolia” OR “Vitis quinquefolia” OR “Virginia creeper”) AND (“antioxidant” OR “anti-inflammatory” OR “bioactive” OR “phytochemical” OR “stilbene” OR “phenolic” OR “flavonoid”). Database-specific search strings are provided in Supplementary Material (Table S1), in-cluding search dates, Boolean operators, and applied filters.

2.4. Study Selection

All records identified through database searching were imported into a reference manager and duplicates were removed. The screening process followed the PRISMA 2020 recommendations and was conducted in two stages. In the first stage, two reviewers independently screened titles and abstracts. Records were excluded at this stage if they met any of the following criteria: (1) non-original publications (e.g., reviews, conference abstracts, book chapters), (2) studies not focusing on Parthenocissus quinquefolia, or (3) absence of biological, phytochemical, antioxidant, or anti-inflammatory outcomes. Full-text articles were then retrieved for all records that passed the initial screening. In the second stage, the same reviewers independently assessed full-text eligibility. Full-text exclusions were applied for the following reasons: (1) full text not accessible, (2) language not meeting inclusion criteria, (3) absence of relevant biological outcomes, or (4) unclear plant identification. Discrepancies at any screening stage were resolved by discussion and consensus. No automation tools were used during the selection process.

2.5. Methodological Quality Assessment

Because the included evidence consisted of phytochemical characterizations and non-clinical experimental studies (in vitro/in vivo), traditional clinical risk of bias tools (e.g., RoB 2, ROBINS-I) were not applicable. Instead, methodological quality was assessed using criteria adapted for non-clinical research, including: (1) botanical identification, (2) extraction reporting, (3) analytical validation, (4) use of controls in bioassays, and (5) replication reporting. Two reviewers independently assessed methodological quality, and disagreements were resolved by consensus.

3. Results

A total of 665 records were identified through database searching, and an additional 2 records were identified through other sources. Before screening, 26 records were removed. A total of 639 records were screened at the title and abstract level, resulting in the exclusion of 349 records for not meeting the inclusion criteria. Full texts were sought for 290 records, of which 177 could not be retrieved. The remaining 113 full-text reports were assessed for eligibility. Of these, 99 were excluded due to being case reports, letters to the editor, presenting irrelevant data, or being published in a non-eligible language. In parallel, two additional reports identified through other sources were assessed, both of which were excluded for the same reasons. Ultimately, 14 studies met the inclusion criteria and were incorporated into the systematic review. The updated PRISMA 2020 flow diagram is shown in Figure 2. All included studies were written in English and consisted exclusively of laboratory work without human or animal intervention. The studies originated from a broad geographical distribution, including Pakistan (n = 2), Ukraine (n = 2), and one study each from Japan, China, Thailand, Tunisia, India, Iran, Turkey, the United States, Hungary, and Saudi Arabia. The included research focused on phytochemical analyses and non-clinical assays performed on different plant parts of P. quinquefolia, including leaves, fruits, stems, and shoots. Analytical approaches varied, encompassing colorimetric assays, chromatographic profiling (e.g., HPLC, HPLC-MS), and spectrophotometric quantification. Experimental models included antioxidant capacity assays (e.g., DPPH, ABTS, FRAP) and other non-interventional in vitro assays. The main characteristics of the included studies are summarized in Table 1.
The included studies focused on extracting and determining the chemical composition of different parts of P. quinquefolia, as well as their possible biological effects. Based on the extracted information, the properties of the species were categorized according to: (i) the plant parts used (stems, leaves, fruits, shoots), (ii) the type of extracts obtained, and (iii) the biological effects evaluated by the authors. These categories are summarized in Table 2.

4. Discussion

4.1. Phytochemical Profile of Parthenocissus quinquefolia

Available evidence indicates that P. quinquefolia contains a diverse spectrum of phenolic secondary metabolites, particularly flavonoids and stilbenoids, which represent the most consistently reported bioactive constituents of the species (Table 2). Phenolic compounds are biosynthesized through the phenylpropanoid pathway and are characterized by at least one aromatic ring bearing hydroxyl substituents. Structurally, they encompass several subclasses, of which flavonoids and stilbenes are the most relevant in P. quinquefolia due to their antioxidant and anti-inflammatory potential [32,33,34,35,36,37,38].

4.1.1. Flavonoids

Flavonoids are low-molecular-weight polyphenols defined by a C6–C3–C6 backbone. In P. quinquefolia, flavonoids reported include flavonols (e.g., quercetin and glycosylated derivatives) and flavan-3-ols (e.g., catechin and epicatechin), mostly detected in leaves, shoots and fruits. These compounds have been associated with radical-scavenging activity, metal chelation, and modulation of redox-sensitive signaling pathways such as NF-κB and Nrf2/ARE in broader pharmacological literature, providing mechanistic plausibility for the antioxidant and anti-inflammatory effects observed in the plant.
Among detected flavonols, quercetin and rutin are particularly relevant. Quercetin has been widely characterized as an antioxidant through direct ROS scavenging as well as activation of endogenous enzymatic defenses via Nrf2, whereas glycosylated forms such as rutin display enhanced stability and documented anti-inflammatory effects via NF-κB inhibition [39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57]. Although these mechanistic properties have been largely demonstrated in non-Parthenocissus systems, their presence in P. quinquefolia suggests functional relevance within its phytochemical matrix.
Flavan-3-ols such as catechin and epicatechin have also been reported. These compounds possess catechol-type moieties that enhance redox activity and exhibit documented interactions with endothelial nitric oxide synthase and pro-inflammatory cytokine signaling, supporting a role in vascular redox modulation [58,59,60,61,62,63,64,65,66,67,68,69,70]. Their occurrence in P. quinquefolia aligns with the polyphenolic profiles documented in other Vitaceae.

4.1.2. Stilbenoids

Stilbenes constitute another major phenolic class in P. quinquefolia. The species contains resveratrol and a range of resveratrol-derived oligomers (e.g., parthenocissins and ε-viniferin), expanding its stilbenoid repertoire beyond that of many related taxa [24,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92]. Structural oligomerization enhances π-electron delocalization and increases the number of accessible phenolic hydroxyl groups, properties associated with superior radical-scavenging and anti-inflammatory capacity relative to monomeric resveratrol [93,94,95,96,97,98,99,100,101,102,103,104,105].
Notably, parthenocissin-type oligomers have been isolated from the genus Parthenocissus, including dimers and higher-order oligomers. Although their functional characterization remains limited in P. quinquefolia, studies from other Vitaceae demonstrate inhibition of NF-κB and COX-2/iNOS expression by related oligomers such as ε-viniferin, supporting mechanistic plausibility for anti-inflammatory effects [106,107,108,109,110,111,112,113,114,115,116,117,118].
Among the studies included, antioxidant activity was evaluated exclusively through chemical in vitro assays, mainly DPPH, ABTS and FRAP, demonstrating relevant radical-scavenging and reducing capacity of extracts from leaves, shoots and fruits. However, no studies were found assessing antioxidant effects in cell-based models, animal models or clinical settings, and no biomarker-based evaluations (e.g., lipid peroxidation, protein oxidation, antioxidant enzymes) have been reported to date for P. quinquefolia. This gap prevents extrapolation of the in vitro antioxidant findings to physiological or therapeutic contexts and highlights the need for validation in biological systems. The findings of this review support that P. quinquefolia represents a relevant source of phenolic metabolites, in particular flavonoids and stilbenoids, capable of modulating central redox-inflammatory pathways such as NF-κB, COX-2/iNOS and the generation of PGE2/NO. This body of evidence provides biological plausibility to the antioxidant and anti-inflammatory effects attributed to the species. The most direct phytochemical and functional information derive from the studies on leaves, shoots and fruits, where flavones, flavonols and catechins (i.e., quercetin, quercetin-3-β-glucoside, rutin, catechin and epicatechin) have been identified and quantified, together with antioxidant activity evaluated by chemical assays. Taken together, this background confirms that the species harbors a complex polyphenolic matrix with significant bioactive potential (Figure 3 and Figure 4) [24,31].
A noteworthy aspect is the identification of resveratrol in P. quinquefolia [119], together with novel resveratrol oligomers, such as parthenocissin M and N [18]. These findings expand the stilbenoid repertoire of the species and suggest that part of its biological activity could be attributed to these higher-order assemblages. These oligomers exhibit distinct biological profiles compared to the monomer [24,120]. From a mechanistic perspective, the Vitaceae literature provides elements that enable the formulation of reasonable hypotheses without undue extrapolation. For example, in Vitis heyneana the trans-ε-viniferin dimer has been shown to suppress NF-κB activation and reduce COX-2/iNOS expression, thereby decreasing the dose-dependent production of PGE2 and NO in LPS-stimulated RAW 264.7 macrophages [118]. Given that P. quinquefolia contains stilbenoids and shares biosynthetic pathways with Vitis, including the production of viniferins and miyabenols [24,120,121], it is plausible that analogous oligomers present in this species contribute to anti-inflammatory effects through convergent molecular targets. In this context, the trimer miyabenol C, isolated and characterized in different Vitaceae [24,121,122], has been associated with neuroprotective effects involving β-secretase inhibition and β-amyloid reduction, indicating a functional spectrum that goes beyond redox modulation and reaches key proteases in amyloidogenesis [123]. Although these results derive from studies on Vitis thunbergii var. taiwaniana [123], they reinforce the idea that resveratrol oligomers may exhibit bioactivities superior or complementary to those of the monomer and may contribute to part of the effects reported in P. quinquefolia. With respect to flavonoids, the compounds detected in P. quinquefolia, such as rutin, quercetin and its glycosides (e.g., quercetin-3-O-alpha-L-rhamnoside) [119], catechin, epicatechin, and luteolin in the fruits, are supported by substantial mechanistic evidence. Quercetin and its glycosylated derivatives modulate the Nrf2/ARE pathway and repress NF-κB activation, reducing the expression of pro-inflammatory cytokines and COX-2, while strengthening enzymatic antioxidant defenses [124]. Recent advances in the broader pharmacological literature further expand the biological relevance of quercetin beyond its antioxidant and anti-inflammatory roles. A narrative review published in Nutrients (2025) highlights quercetin as a bioactive compound involved in women’s reproductive health, reporting modulatory effects on hormonal balance, fertility parameters, and gynecological disorders such as polycystic ovary syndrome, recurrent miscarriage, and endometrial cancer [125,126,127,128,129,130,131,132,133,134,135]. The authors describe molecular pathways through which quercetin may exert such effects, including PI3K/AKT, Nrf2, NF-κB, and other hormone-regulated signaling cascades, underscoring its ability to influence oxidative stress, inflammation, and endocrine regulation in reproductive tissues. These findings reinforce the broader pharmacological potential of quercetin as a principal phenolic constituent of P. quinquefolia, suggesting that its relevance may extend into reproductive and metabolic domains, although these hypotheses remain speculative until directly validated in this species. On the other hand, catechin and epicatechin, present in various Vitaceae species, exert antioxidant effects through direct redox activity and metal chelation and attenuate inflammation associated with oxidative stress and lipotoxic processes in cell and animal models [125]. In addition, kaempferol, identified in Parthenocissus species (specifically P. tricuspidata) [126], and widely distributed within the Vitaceae family, exhibits radical scavenging activity and modulates inflammatory pathways by inhibiting NF-κB and reducing mediators such as iNOS and COX-2 [127]. Taken together, this evidence suggests that the antioxidant and anti-inflammatory effects observed in P. quinquefolia may derive from the combined action of these flavonols, in interaction with catechins, on convergent molecular networks related to oxidative stress and inflammatory signaling. However, the specific participation of Nrf2 and the possible synergies between these compounds need to be evaluated directly in this species.
Beyond the polyphenolic profile of the photosynthetic organs, the biology of the tendrils and adhesion disks provides a distinctive chemical and structural component whose phytochemistry remains practically unexplored. Tendrils, described in Vitaceae for more than three centuries [128], are flexible, branched structures that, in species such as P. quinquefolia, develop expanded adhesive disks at the apexes, allowing attachment to the substrate by flattening and secreting mucilage [129,130]. In this species, adhesion does not depend on the coil, but on an adhesive composed of branched rhamnogalacturonan I, callose and mucilaginous pectins [131]. The formation of the disks involves the accumulation of mucilage, adjustment to the microrelief of the support, and subsequent lignification, which confers high environmental resistance [132]. Although tendrils are recognized as structures with medicinal value in several Vitaceae [133], to the best of our knowledge, there are no studies evaluating the bioactive properties of adhesive disks. This knowledge gap points to a concrete opportunity to investigate the relationship between its specialized polysaccharide composition and potential anti-inflammatory or antioxidant applications in Parthenocissus. Considering the range of antioxidant, anti-inflammatory and, in some cases, neuroprotective activities described for the flavonoids and stilbenoids present in P. quinquefolia, as well as the structural and polysaccharide properties of its tendrils and adhesive disks, the species emerges as a promising candidate for the development of standardized extracts, nutraceutical supplements and possible drugs derived from natural products. The combination of phenolic compounds, with extensive mechanistic support, and less-studied oligomeric metabolites suggests a synergistic potential that could be exploited in both anti-inflammatory interventions and strategies aimed at controlling oxidative stress or protecting tissues. However, moving towards biomedical applications requires validating the safety, bioavailability and in vivo efficacy of these compounds and their mixtures, as well as deepening the characterization of metabolites typical of specialized structures such as adhesion disks. The interpretation of the present findings requires consideration of biogeographical factors. All included studies were conducted on specimens collected in the Northern Hemisphere, where climatic conditions, photoperiod, temperature gradients and soil composition differ substantially from those in Chile. It is well-established that secondary metabolite biosynthesis in plants is modulated by environmental parameters such as UV exposure, temperature, water availability, altitude and soil nutrients, which may influence both the qualitative and quantitative profiles of phenolic compounds. Therefore, it is plausible that specimens of P. quinquefolia growing in Chile could exhibit distinct phenolic fingerprints either in relative abundance or in the presence of specific metabolites when compared to those reported in the literature. Comparative metabolomic studies would be required to confirm whether the stilbenoid and flavonoid profiles described in Northern Hemisphere populations are conserved under Chilean ecological conditions. In the Chilean context, a Mediterranean hotspot highly vulnerable to climate change and environmental oxidative stress, the characterization of antioxidant compounds from P. quinquefolia gains additional relevance [134,135]. Moreover, the widespread use of this species in nature-based solutions, especially in Mediterranean-type climates such as Chile, underscores the importance of understanding its phytochemical composition to more accurately assess its biological value and potential functional applications.

4.2. Limitations

Several methodological limitations should be considered when interpreting the findings of this review. First, the primary studies exhibited substantial heterogeneity in extraction procedures (e.g., solvent polarity, extraction temperature, ultrasound-assisted extraction), plant material selection (leaves, stems, fruits, roots), and phytochemical processing, all of which influence metabolite yield and composition. Second, analytical approaches varied across studies, ranging from qualitative phytochemical screening to quantitative chromatographic techniques (e.g., HPLC, HPLC-MS, GC-MS), limiting comparability of reported metabolite profiles. Third, biological assays used to assess antioxidant and anti-inflammatory activity were not standardized, with studies employing diverse in vitro systems (e.g., DPPH, ABTS, FRAP, NO scavenging, COX-2/iNOS expression assays), preventing direct aggregation of results. Fourth, the absence of in vivo or clinical studies restricts the translational interpretation of the reported bioactivities. Finally, the review design itself was limited by the lack of meta-analytic synthesis due to insufficiently homogeneous data and by the possibility of publication bias toward positive findings. Taken together, these factors warrant cautious interpretation and highlight the need for standardized, mechanistic, and in vivo investigations.

5. Conclusions

In conclusion, available evidence suggests that P. quinquefolia is a notable source of secondary metabolites (particularly polyphenols, flavonoids, and stilbenoids) with documented chemoprotective, antioxidant, and anti-inflammatory activities. These properties underscore its value not only as an ornamental or ethnobotanical species but also as a promising model for contemporary biomedical research. The polyphenols characterized in the species, including catechin, epicatechin, quercetin, myricetin, resveratrol and several resveratrol-derived oligomers (parthenocissins), act on central molecular pathways such as NF-κB, NLRP3, MAPKs, eNOS and Nrf2, thereby modulating oxidative stress and chronic inflammatory responses; processes implicated in cardiovascular, metabolic and neurodegenerative diseases, as well as in oncogenesis and aging. Although the existing body of literature (14 studies) is primarily based on in vitro assays and still lacks validation in animal models or clinical settings, the findings collectively suggest that P. quinquefolia is a credible natural source for the development of extracts, nutraceutical formulations, and lead compounds for drug discovery. Advancing towards translational applications will require rigorous studies addressing bioavailability, safety and in vivo efficacy to substantiate its therapeutic potential in conditions driven by oxidative stress and inflammation.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/antiox15020169/s1.

Author Contributions

Conceptualization, Á.B.; methodology, Á.B. and F.S.; software, F.S.; validation, Á.B., D.M. and J.J.V.-F.; formal analysis, Á.B., F.S., D.M. and M.E.C.; investigation, Á.B., F.S., D.M., A.V. and M.E.C.; resources, D.M. and J.E.L.-R.; data curation, F.S. and Á.B.; writing—drafting the original manuscript, Á.B., F.S. and M.E.C.; writing: review and editing, Á.B., F.S., D.M. and J.J.V.-F.; visualization, Á.B. and M.E.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing does not apply to this article.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

PRISMAPreferred reporting items for systematic reviews and meta-analyses
OSFOpen science framework
PCsPhenolic compounds
NNitrogen
SSulphur
ROSReactive oxygen species
NF-κBNuclear factor kappa B
NONitric oxide
eNOSEndothelial nitric oxide synthase
TGF-βTransforming growth factor-beta
LPSLipopolysaccharide
TNFαTumor necrosis factor-alpha
CRPC-reactive protein
SAASerum amyloid A
ORACOxygen radical absorbance capacity
AP-1Activator protein 1
MCP-1Monocyte chemotactic protein 1
MMP-2Matrix metalloproteinase-2
NLRP3NOD-like receptor heat domain-associated protein 3
ILInterleukin
ATPAdenosine triphosphate
iNOSInducible nitric oxide synthase
COXCyclooxygenase
RNSReactive nitrogen species
SODSuperoxide dismutase
CATCatalase
Nrf2Nuclear factor erythroid 2-related factor 2
HIVHuman immunodeficiency virus
HBVHepatitis B virus
HSVHerpes simplex virus
LDLLow-density lipoprotein
NASHNon-alcoholic steatohepatitis
MAPKsMitogen-activated protein kinas
RCSReactive chlorine species
HO-1Heme oxygenase-1
PPARγPeroxisome proliferator-activated receptor gamma
SIRT1Sirtuin-1
PGE2Prostaglandin E2
CLAConjugated linoleic acid
AREAntioxidant response element

References

  1. Blinkova, O.; Makarenko, N.; Raichuk, L.; Havrylnuk, Y.; Grabovska, T.; Roubik, H. Invasion of Parthenocissus quinquefolia (L.) Planch in the forest-steppe of Ukraine. Ecol. Quest. 2022, 34, 35–44. [Google Scholar] [CrossRef]
  2. Colasoanto, M. Parthenocissus quinquefolia. In Fire Effects Information System; USDA: Washington, DC, USA, 1991. Available online: https://www.fdacs.gov/Agriculture-Industry/Plants-and-Nurseries (accessed on 22 April 2025).
  3. Salehi, B.; Sharifi-Rad, J.; Herrera-Bravo, J.; Salazar, L.A.; Delporte, C.; Barra, G.V.; Cazar Ramirez, M.E.; López, M.D.; Ramírez-Alarcón, K.; Cruz-Martins, N.; et al. Ethnopharmacology, Phytochemistry and Biological Activities of Native Chilean Plants. Curr. Pharm. Des. 2021, 27, 953–970. [Google Scholar] [CrossRef] [PubMed]
  4. Alfaro, S. Antioxidant activity and phytoactive compounds related to biological effects present in native southern Chilean plants: A review. J. Chil. Chem. Soc. 2025, 69, 6115–6128. [Google Scholar] [CrossRef]
  5. Francis, J.K. Wildland S1hrubs of the United States and Its Territories; USDA: San Juan, PR, USA, 2004; Volume 1, pp. 542–544. Available online: https://www.fdacs.gov/Divisions-Offices/Florida-Forest-Service (accessed on 23 April 2025).
  6. Zardi-Bergaouia, A.; Jouinia, M.; Znatia, M.; El Ayeb-Zakhamab, A.; Janneta, H.B. Physico-chemical properties, composition and antioxidant activity of seed oil from the Tunisian Virginia Creeper (Parthenocissus quinquefolia (L.) planch). J. Tunis. Chem. Soc. 2016, 18, 89–95. [Google Scholar]
  7. Khan, Z.; Faisal, S.; Anjum, P.; Sardar, A.A.; Siddiqui, S.Z. Phytochemical properties and antioxidant activities of leaves and fruits extracts of Parthenocissus quinquefolia (L.) Planch. Bangladesh J. Bot. 2018, 47, 33–38. [Google Scholar]
  8. Frase, D.M.; Bannon, S. Contact Dermatitis From Exposure to Virginia Creeper (Parthenocissus quinquefolia): A Deviation From the Saying “Leaves of Three, Let It Be”. Cureus 2025, 17, e86240. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  9. Kumar, S.; Kunaparaju, N.; Zito, S.W.; Barletta, M.A. Effect of Wrightia tinctoria and Parthenocissus quinquefolia on blood glucose and insulin levels in the Zucker diabetic rat model. J. Complement. Integr. Med. 2011, 8, 1. [Google Scholar] [CrossRef]
  10. Faisal, S.; Perveen, A.; Khan, Z.U.; Sardar, A.A.; Shaheen, S.; Manzoor, A. Phytochemical screening and antioxidant potential of Parthenocissus quinquefolia (L.) planch extracts of bark and stem. Pak. J. Pharm. Sci. 2018, 31, 1813–1816. [Google Scholar]
  11. Cömert Önder, F.; Kalın, S.; Maraba, Ö.; Önder, A.; Ilgın, P.; Karabacak, E. Anticancer, Antioxidant, Antimicrobial Activities, and HPLC Analysis of Alcoholic Extracts of Parthenocissus quinquefolia L. Plant Collected from Çanakkale. J. Adv. Res. Nat. Appl. Sci. 2024, 10, 116–133. [Google Scholar] [CrossRef]
  12. Theodoridis, S.; Drakou, E.G.; Hickler, T.; Thines, M.; Nogues-Bravo, D. Evaluating natural medicinal resources and their exposure to global change. Lancet Planet Health 2023, 7, e155–e163. [Google Scholar] [CrossRef]
  13. Pagare, S.; Bhatia, M.; Tripathi, N.; Pagare, S.; Bansal, Y.K. Secondary metabolites of plants and their role: Overview. Curr. Trends Biotechnol. Pharm. 2015, 9, 293–304. [Google Scholar]
  14. Elshafie, H.S.; Camele, I.; Mohamed, A.A. A Comprehensive Review on the Biological, Agricultural and Pharmaceutical Properties of Secondary Metabolites Based-Plant Origin. Int. J. Mol. Sci. 2023, 24, 3266. [Google Scholar] [CrossRef] [PubMed]
  15. Wawrosch, C.; Zotchev, S.B. Production of bioactive plant secondary metabolites through in vitro technologies—Status and outlook. Appl. Microbiol. Biotechnol. 2021, 105, 6649–6668. [Google Scholar] [CrossRef] [PubMed]
  16. Li, X.; Li, C.; Zhang, W.; Wang, Y.; Qian, P.; Huang, H. Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct. Target. Ther. 2023, 8, 239. [Google Scholar] [CrossRef] [PubMed]
  17. Marchi, S.; Guilbaud, E.; Tait, S.W.G.; Yamazaki, T.; Galluzzi, L. Mitochondrial control of inflammation. Nat. Rev. Immunol. 2023, 23, 159–173. [Google Scholar] [CrossRef]
  18. Zhang, H.; Tsao, R. Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr. Opin. Food Sci. 2016, 8, 33–42. [Google Scholar] [CrossRef]
  19. Griffiths, K.; Aggarwal, B.B.; Singh, R.B.; Buttar, H.S.; Wilson, D.; De Meester, F. Food Antioxidants and Their Anti-Inflammatory Properties: A Potential Role in Cardiovascular Diseases and Cancer Prevention. Diseases 2016, 4, 28. [Google Scholar] [CrossRef]
  20. Merecz-Sadowska, A.; Sadowski, A.; Zielińska-Bliźniewska, H.; Zajdel, K.; Zajdel, R. Network Pharmacology as a Tool to Investigate the Antioxidant and Anti-Inflammatory Potential of Plant Secondary Metabolites-A Review and Perspectives. Int. J. Mol. Sci. 2025, 26, 6678. [Google Scholar] [CrossRef]
  21. Muscolo, A.; Mariateresa, O.; Giulio, T.; Mariateresa, R. Oxidative Stress: The Role of Antioxidant Phytochemicals in the Prevention and Treatment of Diseases. Int. J. Mol. Sci. 2024, 25, 3264. [Google Scholar] [CrossRef]
  22. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 29, 372:n71. [Google Scholar]
  23. Tanaka, T.; Linuma, M.; Murata, H. Stilbene derivates in the stem of Parthenocissus quinquefolia. Phytochemistry 1998, 48, 1045–1049. [Google Scholar] [CrossRef]
  24. Yang, J.B.; Wang, A.G.; Ji, T.F.; Su, Y.L. Two new oligostilbenes from the stem of Parthenocissus quinquefolia. J. Asian Nat. Prod. Res. 2014, 16, 275–280. [Google Scholar] [CrossRef] [PubMed]
  25. Rattanata, N.; Sakda, D.; Suthep, P.; Wandee, B.; Bundit, P.; Ratree, T.; Phangthip, U.; Parcharee, B.; Jureerut, D. Antioxidant and antibacterial properties of selected Thai weed extracts. Asian Pac. J. Trop. Biomed. 2014, 4, 890–895. [Google Scholar] [CrossRef]
  26. Deshmukh-Omraj, S. Preliminary phytochemical screening and antibacterial activity of Parthenocissus quinquefolia (L.) Planch. Int. J. Life Sci. 2017, 8, 68–71. [Google Scholar]
  27. Mohamed, A.A.; Salah, M.M.; El-Dein, M.M.Z.; EL-Hefny, M.; Ali, H.M.; Farraj, D.A.A.; Hatamleh, A.A.; Salem, M.Z.M.; Ashmawy, N.A. Ecofriendly Bioagents, Parthenocissus quinquefolia, and Plectranthus neochilus Extracts to Control the Early Blight Pathogen (Alternaria solani) in Tomato. Agronomy 2021, 11, 911. [Google Scholar] [CrossRef]
  28. Ben Ticha, M.; Meksi, N.; Attia, H.E.; Haddar, W.; Guesmi, A.; Ben Jannet, H.; Mhenni, M.F. Ultrasonic extraction of Parthenocissus quinquefolia colorants: Extract identification by HPLC-MS analysis and cleaner application on the phytodyeing of natural fibres. Dye. Pigment. 2017, 141, 103–111. [Google Scholar] [CrossRef]
  29. Makhynia, L.; Yemelianova, O. Anatomical and phytochemical study leaves of Parthenocissus quinquefolia (L.) Planch. Phytother. J. 2023, 3, 108–112. [Google Scholar] [CrossRef]
  30. Konovalova, O.; Yashchuk, B.; Hurtovenko, I.; Shcherbakova, O.; Kalista, M.; Sydora, N. Study on content of flavonoids and antioxidant activity of the raw materials of Parthenocissus quinquefolia (L.) Planch. Sci. Pharm. Sci. 2023, 6, 87–95. [Google Scholar] [CrossRef]
  31. Rónavári, A.; Balázs, M.; Szilágyi, Á.; Molnár, C.; Kotormán, M.; Ilisz, I.; Kiricsi, M.; Kónya, Z. Multi-round recycling of green waste for the production of iron nanoparticles: Synthesis, characterization, and prospects in remediation. Discov. Nano 2023, 18, 8. [Google Scholar] [CrossRef] [PubMed]
  32. Fang, X.; Yang, C.Q.; Wei, Y.K.; Ma, Q.X.; Yang, L.; Chen, X.Y. Genomics grand for diversified plant secondary metabolites. Plant Div. Res. 2011, 33, 53–64. [Google Scholar]
  33. Verpoorte, R.; Alfermann, A.W. Metabolic Engineering of Plant Secondary Metabolism; Kluwer Academic Publishers: Dordrecht, The Netherlands, 2000; pp. 1–23. Available online: https://www.uv.mx/personal/tcarmona/files/2019/02/Verpoorte-y-Alfermann-2000.pdf (accessed on 23 April 2025).
  34. Tsao, R. Chemistry and biochemistry of dietary polyphenols. Nutrients 2010, 2, 1231–1246. [Google Scholar] [CrossRef]
  35. Albuquerque, B.R.; Heleno, S.A.; Oliveira, M.B.; Barros, L.; Ferreira, I.C. Phenolic compounds: Current industrial aplications, limitations and future challenges. Food Funct. 2021, 12, 14–29. [Google Scholar] [CrossRef]
  36. Bruneton, J. Farmacognosia: Fitoquímica y Plantas Medicinales, 2nd ed.; Editorial ACRIBIA: Madrid, España, 1993; pp. 305–341. Available online: https://tejadarossi.wordpress.com/wp-content/uploads/2017/01/farmacognosia_bruneton.pdf (accessed on 25 April 2025).
  37. Lim, I.; Ha, J. Biosynthetic Pathway of Proanthocyanidins in Major Cash Crops. Plants 2021, 10, 1792. [Google Scholar] [CrossRef]
  38. Panche, A.N.; Diwan, A.D.; Chandra, S.R. Flavonoids: An overview. J. Nutr. Sci. 2016, 5, e47, Erratum in J. Nutr. Sci. 2025, 14, e11. https://doi.org/10.1017/jns.2024.73. [Google Scholar] [CrossRef]
  39. Westerterp-Plantenga, M.S. Green tea catechins, caffeine and body-weight regulation. Physiol. Behav. 2010, 100, 42–46. [Google Scholar] [CrossRef]
  40. Jin, J.S.; Touyama, M.; Hisada, T.; Benno, Y. Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiol. Immunol. 2012, 56, 729–739. [Google Scholar] [CrossRef]
  41. Marais, J.P.J.; Deavours, B.; Dixon, R.A.; Ferreira, D. The Stereochemistry of Flavonoids. In The Science of Flavonoids; Grotewold, E., Ed.; Springer: New York, NY, USA, 2006; pp. 1–46. Available online: https://link.springer.com/chapter/10.1007/978-0-387-28822-2_1 (accessed on 25 April 2025).
  42. Anitha, S.; Krishnan, S.; Senthilkumar, K.; Sasirekha, V. Theoretical investigation on the structure and antioxidant activity of (+) catechin and (−) epicatechin—A comparative study. Mol. Phys. 2020, 118, e1745917. [Google Scholar] [CrossRef]
  43. Shay, J.; Elbaz, H.A.; Lee, I.; Zielske, S.P.; Malek, M.H.; Hüttemann, M. Mechanism and Therapeutic Effects of (-) Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration. Oxidative Med. Cell. Longev. 2015, 2015, 181260. [Google Scholar] [CrossRef]
  44. Ramirez-Sanchez, I.; Maya, L.; Ceballos, G.; Villarreal, F. (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension 2010, 55, 1398–1405. [Google Scholar] [CrossRef] [PubMed]
  45. Wu, C.; Suzuki, K. The Effects of Flavonoids on Skeletal Muscle Mass, Muscle Function, and Physical Performance in Individuals with Sarcopenia: A Systematic Review of Randomized Controlled Trials. Nutrients 2023, 15, 3897. [Google Scholar] [CrossRef] [PubMed]
  46. Yang, D.J.; Liu, S.C.; Chen, Y.C.; Hsu, S.H.; Chang, Y.P.; Lin, J.T. Three Pathways Assess Anti-Inflammatory Response of Epicatechin with Lipopolysaccharide-Mediated Macrophage RAW264.7 Cells. J. Food Biochem. 2015, 39, 334–343. [Google Scholar] [CrossRef]
  47. Vazquez-Prieto, M.A.; Bettaieb, A.; Haj, F.G.; Fraga, C.G.; Oteiza, P.I. (-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 2012, 527, 113–118, Erratum in Arch. Biochem. Biophys. 2024, 756, 109992. [Google Scholar] [CrossRef]
  48. Schroeter, H.; Heiss, C.; Balzer, J.; Kleinbongard, P.; Keen, C.L.; Hollenberg, N.K.; Sies, H.; Kwik-Uribe, C.; Schmitz, H.H.; Kelm, M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA 2006, 103, 1024–1029. [Google Scholar] [CrossRef] [PubMed]
  49. Morrison, M.; van der Heijden, R.; Heeringa, P.; Kaijzel, E.; Verschuren, L.; Blomhoff, R.; Kooistra, T.; Kleemann, R. Epicatechin attenuates atherosclerosis and exerts anti-inflammatory effects on diet-induced human-CRP and NFκB in vivo. Atherosclerosis 2014, 233, 149–156. [Google Scholar] [CrossRef]
  50. Nakagawa, K.; Miyazawa, T. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J. Nutr. Sci. Vitaminol. 1997, 43, 679–684. [Google Scholar] [CrossRef] [PubMed]
  51. Frei, B.; Higdon, J.V. Antioxidant activity of tea polyphenols in vivo: Evidence from animal studies. J. Nutr. 2003, 133, 3275S–3284S. [Google Scholar] [CrossRef] [PubMed]
  52. Ahmed, S.; Pakozdi, A.; Koch, A.E. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2006, 54, 2393–2401. [Google Scholar] [CrossRef]
  53. Lee, H.E.; Yang, G.; Park, Y.B.; Kang, H.C.; Cho, Y.Y.; Lee, H.S.; Lee, J.Y. Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis. Molecules 2019, 24, 2138. [Google Scholar] [CrossRef]
  54. Gerges Geagea, A.; Rizzo, M.; Eid, A.; Hajj Hussein, I.; Zgheib, Z.; Zeenny, M.N.; Jurjus, R.; Uzzo, M.L.; Spatola, G.F.; Bonaventura, G.; et al. Tea catechins induce crosstalk between signaling pathways and stabilize mast cells in ulcerative colitis. J. Biol. Regul. Homeost. Agents 2017, 31, 865–877. [Google Scholar]
  55. Chen, G.; Cheng, K.; Niu, Y.; Zhu, L.; Wang, X. (-)-Epicatechin gallate prevents inflammatory response in hypoxia-activated microglia and cerebral edema by inhibiting NF-κB signaling. Arch. Biochem. Biophys. 2022, 729, 109393. [Google Scholar] [CrossRef]
  56. Wang, H.; Cao, Z.-R. Anti-inflammatory Effects of (-)-Epicatechin in Lipopolysaccharide-Stimulated Raw 264.7 Macrophages. Trop. J. Pharm. Res. 2014, 13, 1415–1419. [Google Scholar] [CrossRef]
  57. Boots, A.W.; Haenen, G.R.; Bast, A. Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585, 325–337. [Google Scholar] [CrossRef]
  58. Mirza, M.A.; Mahmood, S.; Hilles, A.R.; Ali, A.; Khan, M.Z.; Zaidi, S.A.A.; Iqbal, Z.; Ge, Y. Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review. Pharmaceuticals 2023, 16, 1631. [Google Scholar] [CrossRef]
  59. Jazvinšćak Jembrek, M.; Oršolić, N.; Mandić, L.; Sadžak, A.; Šegota, S. Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration. Antioxidants 2021, 10, 1628. [Google Scholar] [CrossRef]
  60. Cheng, S.C.; Huang, W.C.S.; Pang, J.H.; Wu, Y.H.; Cheng, C.Y. Quercetin Inhibits the Production of IL-1β-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-κB Signaling Pathways. Int. J. Mol. Sci. 2019, 20, 2957. [Google Scholar] [CrossRef] [PubMed]
  61. Carrillo-Martinez, E.J.; Flores-Hernández, F.Y.; Salazar-Montes, A.M.; Nario-Chaidez, H.F.; Hernández-Ortega, L.D. Quercetin, a Flavonoid with Great Pharmacological Capacity. Molecules 2024, 29, 1000. [Google Scholar] [CrossRef] [PubMed]
  62. Lee, E.H.; Park, H.J.; Jung, H.Y.; Kang, I.K.; Kim, B.O.; Cho, Y.J. Isoquercitrin isolated from newly bred Green ball apple peel in lipopolysaccharide-stimulated macrophage regulates NF-κB inflammatory pathways and cytokines. 3 Biotech 2022, 12, 100. [Google Scholar] [CrossRef]
  63. Ma, J.; Li, M.; Yang, T.; Deng, Y.; Ding, Y.; Guo, T.; Shang, J. Isoquercitrin Attenuates Steatohepatitis by Inhibition of the Activated NLRP3 Inflammasome through HSP90. Int. J. Mol. Sci. 2023, 24, 8795. [Google Scholar] [CrossRef] [PubMed]
  64. Gullón, B.; Lú-Chau, T.A.; Moreira, M.T.; Lema, J.M.; Eibes, G. Rutin: A review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability. Trends Food Sci. Technol. 2017, 67, 220–235. [Google Scholar] [CrossRef]
  65. Tian, C.; Liu, X.; Chang, Y.; Wang, R.; Yang, M.; Liu, M. Rutin prevents inflammation induced by lipopolysaccharide in RAW 264.7 cells via conquering the TLR4-MyD88-TRAF6-NF-κB signalling pathway. J. Pharm. Pharmacol. 2021, 73, 110–117. [Google Scholar] [CrossRef] [PubMed]
  66. Yeh, C.H.; Yang, J.J.; Yang, M.L.; Li, Y.C.; Kuan, Y.H. Rutin decreases lipopolysaccharide-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-κB pathway. Free. Radic. Biol. Med. 2014, 69, 249–257. [Google Scholar] [CrossRef]
  67. Wu, J.; Maoqiang, L.; Fan, H.; Zhenyu, B.; Qifang, H.; Xuepeng, W.; Liulong, Z. Rutin attenuates neuroinflammation in spinal cord injury rats. J. Surg. Res. 2016, 203, 331–337. [Google Scholar] [CrossRef]
  68. Guardia, T.; Rotelli, A.E.; Juarez, A.O.; Pelzer, L.E. Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 2001, 56, 683–687. [Google Scholar] [CrossRef]
  69. Semwal, D.K.; Semwal, R.B.; Combrinck, S.; Viljoen, A. Myricetin: A Dietary Molecule with Diverse Biological Activities. Nutrients 2016, 8, 90. [Google Scholar] [CrossRef]
  70. Cao, G.; Sofic, E.; Prior, R.L. Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships. Free. Radic. Biol. Med. 1997, 22, 749–760. [Google Scholar] [CrossRef]
  71. Chen, T.; Hu, Y.; Lu, L.; Zhao, Q.; Tao, X.; Ding, B.; Chen, S.; Zhu, J.; Guo, X.; Lin, Z. Myricetin attenuates hypoxic-ischemic brain damage in neonatal rats via NRF2 signaling pathway. Front. Pharmacol. 2023, 14, 1134464. [Google Scholar] [CrossRef] [PubMed]
  72. Imran, M.; Saeed, F.; Hussain, G.; Imran, A.; Mehmood, Z.; Gondal, T.A.; El-Ghorab, A.; Ahmad, I.; Pezzani, R.; Arshad, M.U.; et al. Myricetin: A comprehensive review on its biological potentials. Food Sci. Nutr. 2021, 9, 5854–5868. [Google Scholar] [CrossRef] [PubMed]
  73. Stabrauskiene, J.; Kopustinskiene, D.M.; Lazauskas, R.; Bernatoniene, J. Naringin and Naringenin: Their Mechanisms of Action and the Potential Anticancer Activities. Biomedicines 2022, 10, 1686. [Google Scholar] [CrossRef]
  74. Jiang, H.; Zhang, M.; Lin, X.; Zheng, X.; Qi, H.; Chen, J.; Zeng, X.; Bai, W.; Xiao, G. Biological Activities and Solubilization Methodologies of Naringin. Foods 2023, 12, 2327. [Google Scholar] [CrossRef] [PubMed]
  75. Bharti, S.; Rani, N.; Krishnamurthy, B.; Arya, D.S. Preclinical evidence for the pharmacological actions of naringin: A review. Planta Medica 2014, 80, 437–451. [Google Scholar] [CrossRef]
  76. Kumar, R.P.; Abraham, A. Inhibition of LPS induced pro-inflammatory responses in RAW 264.7 macrophage cells by PVP-coated naringenin nanoparticle via down regulation of NF-κB/P38MAPK mediated stress signaling. Pharmacol. Rep. 2017, 69, 908–915. [Google Scholar] [CrossRef]
  77. Kanno, S.; Tomizawa, A.; Ohtake, T.; Koiwai, K.; Ujibe, M.; Ishikawa, M. Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol. Lett. 2006, 166, 131–139. [Google Scholar] [CrossRef]
  78. Liu, X.; Liu, M.; Mo, Y.; Peng, H.; Gong, J.; Li, Z.; Chen, J.; Xie, J. Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats. Iran. J. Basic Med. Sci. 2016, 19, 417–422. [Google Scholar]
  79. Jeon, S.M.; Bok, S.H.; Jang, M.K.; Lee, M.K.; Nam, K.T.; Park, Y.B.; Rhee, S.J.; Choi, M.S. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci. 2001, 69, 2855–2866. [Google Scholar] [CrossRef]
  80. López-Lázaro, M. Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 2009, 9, 31–59. [Google Scholar] [CrossRef] [PubMed]
  81. Vlocskó, R.B.; Mastyugin, M.; Török, B.; Török, M. Correlation of physicochemical properties with antioxidant activity in phenol and thiophenol analogues. Sci. Rep. 2025, 15, 73. [Google Scholar] [CrossRef] [PubMed]
  82. Rolt, A.; Cox, L.S. Structural basis of the anti-ageing effects of polyphenolics: Mitigation of oxidative stress. BMC Chem. 2020, 14, 50. [Google Scholar] [CrossRef] [PubMed]
  83. Lin, Y.; Shi, R.; Wang, X.; Shen, H.M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets 2008, 8, 634–646. [Google Scholar] [CrossRef]
  84. Chen, C.Y.; Peng, W.H.; Tsai, K.D.; Hsu, S.L. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages. Life Sci. 2007, 81, 1602–1614. [Google Scholar] [CrossRef]
  85. Lee, M.N.; Lee, Y.; Wu, D.; Pae, M. Luteolin inhibits NLRP3 inflammasome activation via blocking ASC oligomerization. J. Nutr. Biochem. 2021, 92, 108614. [Google Scholar] [CrossRef]
  86. Jang, S.; Kelley, K.W.; Johnson, R.W. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc. Natl. Acad. Sci. USA 2008, 105, 7534–7539. [Google Scholar] [CrossRef]
  87. Pandurangan, A.K.; Dharmalingam, P.; Sadagopan, S.K.; Ganapasam, S. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Hum. Exp. Toxicol. 2014, 33, 1176–1185. [Google Scholar] [CrossRef]
  88. Sepehri, S.; Khedmati, M.; Yousef-Nejad, F.; Mahdavi, M. Medicinal chemistry perspective on the structure-activity relationship of stilbene derivatives. RSC Adv. 2024, 14, 19823–19879. [Google Scholar] [CrossRef]
  89. Su, X.; Zhou, D.; Li, N. Bioactive stilbenes from plants. Stud. Nat. Prod. Chem. 2022, 73, 265–403. [Google Scholar]
  90. Baur, J.A.; Sinclair, D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006, 5, 493–506. [Google Scholar] [CrossRef]
  91. Manna, S.K.; Mukhopadhyay, A.; Aggarwal, B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 2000, 164, 6509–6519. [Google Scholar] [CrossRef] [PubMed]
  92. Kundu, J.K.; Surh, Y.J. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets. Mutat Res 2004, 555, 65–80. [Google Scholar] [CrossRef] [PubMed]
  93. Kundu, J.K.; Shin, Y.K.; Kim, S.H.; Surh, Y.J. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 2006, 27, 1465–1474. [Google Scholar] [CrossRef]
  94. Sarubbo, F.; Esteban, S.; Miralles, A.; Moranta, D. Effects of Resveratrol and other Polyphenols on Sirt1: Relevance to Brain Function During Aging. Curr. Neuropharmacol. 2018, 16, 126–136. [Google Scholar] [CrossRef]
  95. Csiszar, A.; Labinskyy, N.; Podlutsky, A.; Kaminski, P.M.; Wolin, M.S.; Zhang, C.; Mukhopadhyay, P.; Pacher, P.; Hu, F.; de Cabo, R.; et al. Vasoprotective effects of resveratrol and SIRT1: Attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol.-Heart Circ. Physiol. 2008, 294, H2721–H2735. [Google Scholar] [CrossRef]
  96. He, S.; Jiang, L.; Wu, B.; Zhou, J.; Pan, Y.J. Two Novel Antioxidative Stilbene Tetramers from Parthenocissus laetevirens. Helv. Chim. Acta 2009, 92, 1260–1267. [Google Scholar] [CrossRef]
  97. Lin, M.; Yao, C.S. Natural Oligostilbenes. Stud. Nat. Prod. Chem. 2006, 33, 601–644. [Google Scholar]
  98. He, S.; Wu, B.; Pan, Y.; Jiang, L. Stilbene oligomers from Parthenocissus laetevirens: Isolation, biomimetic synthesis, absolute configuration, and implication of antioxidative defense system in the plant. J. Org. Chem. 2008, 73, 5233–5241. [Google Scholar] [CrossRef]
  99. He, S.; Yang, J.; Wu, B.; Pan, Y.; Wan, H.; Wang, Y.; Du, Y.; Wang, S. Neuroprotective effect of parthenocissin A, a natural antioxidant and free radical scavenger, in focal cerebral ischemia of rats. Phytother. Res. 2010, 24, S63–S70, Erratum in Phytother. Res. 2010, 24, 632. [Google Scholar] [CrossRef] [PubMed]
  100. Li, C.; Xu, X.; Tao, Z.; Wang, X.J.; Pan, Y. Resveratrol dimers, nutritional components in grape wine, are selective ROS scavengers and weak Nrf2 activators. Food Chem. 2015, 173, 218–223. [Google Scholar] [CrossRef] [PubMed]
  101. Danışman, B.; Ercan Kelek, S.; Aslan, M. Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria. Psychiatry Clin. Psychopharmacol. 2023, 33, 147–155. [Google Scholar] [CrossRef]
  102. Gomes, B.A.Q.; Silva, J.P.B.; Romeiro, C.F.R.; Dos Santos, S.M.; Rodrigues, C.A.; Gonçalves, P.R.; Sakai, J.T.; Mendes, P.F.S.; Varela, E.L.P.; Monteiro, M.C. Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1. Oxidative Med. Cell. Longev. 2018, 2018, 8152373. [Google Scholar] [CrossRef] [PubMed]
  103. Beaumont, P.; Courtois, A.; Atgié, C.; Richard, T.; Krisa, S. In the shadow of resveratrol: Biological activities of epsilon-viniferin. J. Physiol. Biochem. 2022, 78, 465–484, Erratum in J. Physiol. Biochem. 2022, 78, 933. [Google Scholar] [CrossRef]
  104. Fuloria, S.; Sekar, M.; Khattulanuar, F.S.; Gan, S.H.; Rani, N.N.I.M.; Ravi, S.; Subramaniyan, V.; Jeyabalan, S.; Begum, M.Y.; Chidam-baram, K.; et al. Chemistry, Biosynthesis and Pharmacology of Viniferin: Potential Resveratrol-Derived Molecules for New Drug Discovery, Devel-opment and Therapy. Molecules 2022, 27, 5072. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  105. Billard, C.; Izard, J.C.; Roman, V.; Kern, C.; Mathiot, C.; Mentz, F.; Kolb, J.P. Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk. Lymphoma 2002, 43, 1991–2002. [Google Scholar] [CrossRef]
  106. Whitlock, N.C.; Baek, S.J. The anticancer effects of resveratrol: Modulation of transcription factors. Nutr. Cancer 2012, 64, 493–502. [Google Scholar] [CrossRef]
  107. Burdge, G.C.; Calder, P.C. Introduction to fatty acids and lipids. World Rev. Nutr. Diet. 2015, 112, 1–16. [Google Scholar] [PubMed]
  108. Ku, K.T.; Huang, Y.L.; Huang, Y.J.; Chiou, W.F. Miyabenol A inhibits LPS-induced NO production via IKK/IkappaB inactivation in RAW 264.7 macrophages: Possible involvement of the p38 and PI3K pathways. J. Agric. Food Chem. 2008, 56, 8911–8918. [Google Scholar] [CrossRef]
  109. Wallis, C.M. Microplate bioassay to examine the effects of grapevine-isolated stilbenoids on survival of root knot nema-todes. BMC Res. Notes. 2022, 15, 220. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  110. Morvaridzadeh, M.; Estêvão, M.D.; Morvaridi, M.; Belančić, A.; Mohammadi, S.; Hassani, M.; Heshmati, J.; Ziaei, S. The effect of Conjugated Linoleic Acid intake on oxidative stress parameters and antioxidant enzymes: A systematic review and meta-analysis of randomized clinical trials. Prostaglandins Other Lipid Mediat. 2022, 163, 106666. [Google Scholar] [CrossRef] [PubMed]
  111. Kim, Y.; Kim, J.; Whang, K.Y.; Park, Y. Impact of Conjugated Linoleic Acid (CLA) on Skeletal Muscle Metabolism. Lipids 2016, 51, 159–178. [Google Scholar] [CrossRef]
  112. Innes, J.K.; Calder, P.C. Omega-6 fatty acids and inflammation. Prostaglandins Leukot. Essent. Fat. Acids 2018, 132, 41–48. [Google Scholar] [CrossRef] [PubMed]
  113. Green, C.D.; Maceyka, M.; Cowart, L.A.; Spiegel, S. Sphingolipids in metabolic disease: The good, the bad, and the unknown. Cell Metab. 2021, 33, 1293–1306. [Google Scholar] [CrossRef]
  114. Petersen, M.C.; Shulman, G.I. Mechanisms of Insulin Action and Insulin Resistance. Physiol. Rev. 2018, 98, 2133–2223. [Google Scholar] [CrossRef]
  115. Wang, P.; Ni, M.; Tian, Y.; Wang, H.; Qiu, J.; You, W.; Wei, S.; Shi, Y.; Zhou, J.; Cheng, F.; et al. Myeloid Nrf2 deficiency aggravates non-alcoholic steatohepatitis progression by regulating YAP-mediated NLRP3 inflammasome signaling. iScience 2021, 24, 102427, Erratum in iScience 2021, 24, 103335. [Google Scholar] [CrossRef]
  116. Abu-Halaka, D.; Shpaizer, A.; Zeigerman, H.; Kanner, J.; Tirosh, O. DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine. Antioxidants 2023, 12, 512. [Google Scholar] [CrossRef]
  117. Wang, N.; Li, J.Y.; Zeng, B.; Chen, G.L. Sphingosine-1-Phosphate Signaling in Cardiovascular Diseases. Biomolecules 2023, 13, 818. [Google Scholar] [CrossRef]
  118. Soto-Alarcon, S.A.; Valenzuela, R.; Valenzuela, A.; Videla, L.A. Liver Protective Effects of Extra Virgin Olive Oil: Interaction between Its Chemical Composition and the Cell-signaling Pathways Involved in Protection. Endocr. Metab. Immune Disord.-Drug Targets 2018, 18, 75–84. [Google Scholar] [CrossRef]
  119. Boronat, A.; Serreli, G.; Rodríguez-Morató, J.; Deiana, M.; de la Torre, R. Olive Oil Phenolic Compounds’ Activity against Age-Associated Cognitive Decline: Clinical and Experimental Evidence. Antioxidants 2023, 12, 1472. [Google Scholar] [CrossRef]
  120. Tutunchi, H.; Ostadrahimi, A.; Saghafi-Asl, M. The Effects of Diets Enriched in Monounsaturated Oleic Acid on the Management and Prevention of Obesity: A Systematic Review of Human Intervention Studies. Adv. Nutr. 2020, 11, 864–877. [Google Scholar] [CrossRef]
  121. Yang, J.; Wang, A.; Ji, T.; Su, Y. Chemical constituents from Parthenocissus quinquefolia. Zhongguo Zhong Yao Za Zhi 2010, 35, 1573–1576. (In Chinese) [Google Scholar] [PubMed]
  122. Keylor, M.H.; Matsuura, B.S.; Stephenson, C.R. Chemistry and Biology of Resveratrol-Derived Natural Products. Chem. Rev. 2015, 115, 8976–9027. [Google Scholar] [CrossRef]
  123. Ha, D.T.; Long, P.T.; Hien, T.T.; Tuan, D.T.; An, N.T.T.; Khoi, N.M.; Van Oanh, H.; Hung, T.M. Anti-inflammatory effect of oligostilbenoids from Vitis heyneana in LPS-stimulated RAW 264.7 macrophages via suppressing the NF-κB activation. Chem. Cent. J. 2018, 12, 14. [Google Scholar] [CrossRef]
  124. Waffo-Téguo, P.; Shaver, J.; Mérilon, J.M. Stilbenoid chemistry from wine and the genus Vitis, a review. OENO One 2012, 46, 57–111. [Google Scholar] [CrossRef]
  125. Papastamoulis, Y.; Bisson, J.; Temsamani, H.; Richard, T.; Marchal, A.; Mérillon, J.M.; Waffo-Téguo, P. New E-miyabenol isomer isolated from grapevine cane using centrifugal partition chromatography guided by mass spectrometry. Tetrahedron 2015, 71, 3138–3142. [Google Scholar] [CrossRef]
  126. Hu, J.; Lin, T.; Gao, Y.; Xu, J.; Jiang, C.; Wang, G.; Bu, G.; Xu, H.; Chen, H.; Zhang, Y.W. The resveratrol trimer miyabenol C inhibits β-secretase activity and β-amyloid generation. PLoS ONE 2015, 10, e0115973. [Google Scholar] [CrossRef] [PubMed]
  127. Li, Y.; Yao, J.; Han, C.; Yang, J.; Chaudhry, M.T.; Wang, S.; Liu, H.; Yin, Y. Quercetin, Inflammation and Immunity. Nutrients 2016, 8, 167. [Google Scholar] [CrossRef] [PubMed]
  128. Sheng, Y.; Sun, Y.; Tang, Y.; Yu, Y.; Wang, J.; Zheng, F.; Li, Y.; Sun, Y. Catechins: Protective mechanism of antioxidant stress in atherosclerosis. Front. Pharmacol. 2023, 14, 1144878. [Google Scholar] [CrossRef] [PubMed]
  129. Saleem, M.; Kim, H.J.; Jin, C.; Lee, Y.S. Antioxidant caffeic acid derivatives from leaves of Parthenocissus tricuspidata. Arch. Pharmacal Res. 2004, 27, 300–304. [Google Scholar] [CrossRef]
  130. Calderón-Montaño, J.M.; Burgos-Morón, E.; Pérez-Guerrero, C.; López-Lázaro, M. A review on the dietary flavonoid kaempferol. Mini Rev. Med. Chem. 2011, 11, 298–344. [Google Scholar] [CrossRef]
  131. Yang, X.; Deng, W. Review on the adhesive tendrils of Parthenocissus. Chin. Sci. Bull. 2014, 59, 113–124. [Google Scholar] [CrossRef]
  132. Shah, J.J.; Dave, Y.S. Morpho-Histogenic Studies on Tndrild of Vitaceae. Am. J. Bot. 1970, 57, 363–373. [Google Scholar]
  133. Bowling, A.J.; Vaughn, K.C. Structural and immunocytochemical characterization of the adhesive tendril of Virginia creeper (Parthenocissus quinquefolia [L.] Planch.). Protoplasma 2008, 232, 153–163. [Google Scholar] [CrossRef]
  134. Hurrell, J.A.; Delucchi, G.; Cabanillas, P. Primera cita de Parthenocissus tricuspidata y nuevo registro de P. quinquefolia (Vitaceae) adventicias en la Argentina. Rev. Mus. Argent. Cienc. Nat. 2012, 14, 235–242. [Google Scholar] [CrossRef]
  135. Khamineh, Y.; Ghiasvand, M.; Panahi-Alanagh, S.; Rastegarmand, P.; Zolghadri, S.; Stanek, A. A Narrative Review of Quercetin’s Role as a Bioactive Compound in Female Reproductive Disorders. Nutrients 2025, 17, 1118. [Google Scholar] [CrossRef]
Antioxidants 15 00169 g001
Figure 1. Chemical structures of key phenolic metabolites identified in Parthenocissus quinquefolia. (A) Quercetin, (B) Rutin, (C) ε-Viniferin.
Figure 1. Chemical structures of key phenolic metabolites identified in Parthenocissus quinquefolia. (A) Quercetin, (B) Rutin, (C) ε-Viniferin.
Antioxidants 15 00169 g001
Antioxidants 15 00169 g002
Figure 2. PRISMA 2020 flow diagram illustrating the selection of studies included in the review. Adapted from Page et al. (2021) [22].
Figure 2. PRISMA 2020 flow diagram illustrating the selection of studies included in the review. Adapted from Page et al. (2021) [22].
Antioxidants 15 00169 g002
Antioxidants 15 00169 g003
Figure 3. Proposed mechanism for antioxidant activation through the Nrf2/ARE pathway by phenolic metabolites identified in Parthenocissus quinquefolia. Phenolic compounds such as quercetin and myricetin promote Nrf2 nuclear translocation and induction of antioxidant enzymes (e.g., HO-1, SOD, CAT), contributing to redox homeostasis.
Figure 3. Proposed mechanism for antioxidant activation through the Nrf2/ARE pathway by phenolic metabolites identified in Parthenocissus quinquefolia. Phenolic compounds such as quercetin and myricetin promote Nrf2 nuclear translocation and induction of antioxidant enzymes (e.g., HO-1, SOD, CAT), contributing to redox homeostasis.
Antioxidants 15 00169 g003
Antioxidants 15 00169 g004
Figure 4. Proposed mechanism for anti-inflammatory modulation through NF-κB inhibition by phenolic metabolites identified in Parthenocissus quinquefolia. Compounds including catechins, rutin and ε-viniferin reduce IκBα degradation and NF-κB nuclear translocation, downregulating COX-2, iNOS and pro-inflammatory cytokines.
Figure 4. Proposed mechanism for anti-inflammatory modulation through NF-κB inhibition by phenolic metabolites identified in Parthenocissus quinquefolia. Compounds including catechins, rutin and ε-viniferin reduce IκBα degradation and NF-κB nuclear translocation, downregulating COX-2, iNOS and pro-inflammatory cytokines.
Antioxidants 15 00169 g004
Table 1. General characteristics of each selected study (n = 14).
Table 1. General characteristics of each selected study (n = 14).
StudyPlant Part UsedExtraction MethodAnalytical TechniqueIdentified CompoundsConcentrationsAssay Conditions/Biological Assays
Tanaka T., Inuma M. Murata H. (1998) [23]StemsAcetone + Methanol extractsPhytochemistry/ChromatographyParthenocissin A, Parthenocissin BNot reportedAntioxidant activity (in vitro), qualitative
Kumar S. et al. (2011) [9]Not specifiedNot reportedNot reportedNot reported250 mg/kg p.c. (oral)Antidiabetic activity in Zucker rats
Yang J. et al. (2013) [24]StemsEthanol extractHPLC/ChromatographyParthenocissin M, Parthenocissin N, Miyabenol C, ε-viniferinNot reportedHepatoprotective, antibacterial, antifungal assays (in vitro)
Rattanata N. et al. (2014) [25]LeavesEthanol extractColorimetric assaysTotal phenolics, flavonoids (non-specific)TPC/FC values not stated in manuscriptAntioxidant (DPPH, ABTS), Antibacterial assays
Zardi-Bergaoui A. et al. (2016) [6]Pods & seedsSoxhlet extraction (hexane)GC-MSLinoleic acid, Palmitic acid, Oleic acid% composition reported in original study (not provided in manuscript)Antioxidant/Antiradical activity
Deshmukh-Omraj S. (2017) [26]RootsCrude extractQualitative phytochemical screeningAlkaloids, Flavonoids, Terpenoids, Steroids, Coumarins, Carbohydrates, TanninsNot applicable (qualitative)Antibacterial assays (in vitro)
Zaheer-Ud-Din K. et al. (2017) [7]Leaves & fruitsCrude ethanolic extractsQualitative phytochemical screeningTerpenoids, Flavonoids, Saponins, Tannins, Alkaloids, GlycosidesNot applicable (qualitative)Antioxidant assays (DPPH)
Faisal S. et al. (2018) [10]BarkMethanolic extractColorimetric assaysTotal phenolicsTPC value not provided in manuscriptFree radical scavenging assays
Mohamed A. A. et al. (2021) [27]FruitsEthanolic extractHPLCRutin, MyricetinRutin: 1891.60 mg/100 g extract; Myricetin: 241.06 mg/100 g extractAntimicrobial and fungicidal assays
Ticha et al. (2017) [28]FruitsUltrasonic aqueous extractionHPLC-MSAnthocyanins: delphinidin, petunidin, cyanidin, malvidin, peonidin, pelargonidinNot reportedNo biological assays performed (phytodyeing application)
Makhynia L., Yemelianova O. (2023) [29]Leaves (flowering & fruiting stages)Not reportedQualitative phytochemical screeningPhenols, Flavonoids, Polysaccharides, Saponins, Tannins, Catechins, Anthocyanins, Hydroxycinnamic acidsNot applicableNo biological assays performed
Konovalova O. et al. (2023) [30]Leaves, shoots, fruitsEthanol extractHPLCRutin, Quercetin, Quercetin-3-β-glycoside, Naringin (leaves & shoots); Epicatechin, Catechin, Gallocatechin, Epicatechin gallate, Luteolin (fruit)Not reportedAntioxidant assays (DPPH)
Rónavári A. et al. (2023) [31]LeavesGreen extract for nanoparticle synthesisHPLC (phenolics), LC-analysisTotal phenolics, sugars (fructose, glucose, sucrose, mannitol, citric acid)Not reportedNo biological assays performed
Önder FC. et al. (2024) [11]Fruits & red leavesEthanol extractHPLCTotal phenolic content (non-specific)TPC reported in original study (not in manuscript)Anticancer, Antioxidant, Antimicrobial assays
Table 2. Phytochemical and bioactivity characteristics specific to each selected study.
Table 2. Phytochemical and bioactivity characteristics specific to each selected study.
StudyPlant PartIdentified CompoundsQuantificationBioassay TypeBiological Effect
Tanaka T. Inuma M., Murata H. (1998) [23]StemsParthenocissins A, BNot reported (structural identification only)Antioxidant (in vitro)Positive antioxidant activity
Kumar S. et al. (2011) [9]Not specifiedNot reportedNot reportedIn vivo (Zucker diabetic rat model; Oral glucose tolerance; Insulin ELISA)Positive antihyperglycemic effect
Yang J. et al. (2013) [24]StemsParthenocissins M/N, Miyabenol C, ε-viniferinNot reportedChemopreventive, antibacterial, antifungalPositive effects reported
Rattanata N. et al. (2014) [25]LeavesTotal phenolics/flavonoids (nonspecific)TPC/TFC not reportedAntioxidant (DPPH, ABTS), antibacterialPositive activity
Zardi-Bergaoui A. et al. (2016) [6]Pods and seedsLinoleic, palmitic, oleic acidsinhibition DPPH 31.6–83.8%Antioxidant/antiradicalPositive activity
Deshmukh-Omraj S. (2017) [26]RootsVarious phytochemicals (qualitative)Not applicable (qualitative)AntibacterialPositive activity
Ud-Din Khan Z. et al. (2017) [7]Leaves & fruitsTerpenoids, flavonoids, etc. (qualitative)Not applicable (qualitative)Antioxidant (DPPH)Positive activity
Faisal S. et al. (2018) [10]BarkTotal phenolicsIC50 bark ~24.32 mg/mL; stem ~13.6 mg/mLAntioxidantPositive scavenging activity
Mohamed A. A. et al. (2021) [27]FruitsRutin, MyricetinNot reportedAntimicrobial/fungicidalPositive activity
Ticha et al. (2017) [28]FruitsAnthocyanins (delphinidin, petunidin, cyanidin, etc.)Not reportedNot evaluatedNo bioactivity reported
Makhynia L., Yemelianova O. (2023) [29]Leaves (2 stages)Phenolics, flavonoids, etc. (qualitative)Not applicable (qualitative)Not evaluatedNo bioactivity reported
Konovalova O. et al. (2023) [30]Leaves/shoots/fruitsRutin, quercetin, catechins, etc.Not reportedAntioxidant (DPPH)Positive activity
Rónavári A. et al. (2023) [31]LeavesTotal phenolics & sugarsNot reportedNot evaluatedNo bioactivity reported
Cömert Önder F. et al. (2024) [11]Fruits & red leavesTotal phenolicsTPC reported in original study (Not in manuscript)Anticancer, antioxidant, antimicrobialPositive activity
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Becerra, Á.; Soto, F.; Vallejos, A.; Millán, D.; Valenzuela-Fuenzalida, J.J.; Leon-Rojas, J.E.; Cortés, M.E. Bioactive Components of Parthenocissus quinquefolia with Antioxidant and Anti-Inflammatory Properties: A Systematic Review. Antioxidants 2026, 15, 169. https://doi.org/10.3390/antiox15020169

AMA Style

Becerra Á, Soto F, Vallejos A, Millán D, Valenzuela-Fuenzalida JJ, Leon-Rojas JE, Cortés ME. Bioactive Components of Parthenocissus quinquefolia with Antioxidant and Anti-Inflammatory Properties: A Systematic Review. Antioxidants. 2026; 15(2):169. https://doi.org/10.3390/antiox15020169

Chicago/Turabian Style

Becerra, Álvaro, Felipe Soto, Alejandro Vallejos, Daniela Millán, Juan José Valenzuela-Fuenzalida, Jose E. Leon-Rojas, and Manuel E. Cortés. 2026. "Bioactive Components of Parthenocissus quinquefolia with Antioxidant and Anti-Inflammatory Properties: A Systematic Review" Antioxidants 15, no. 2: 169. https://doi.org/10.3390/antiox15020169

APA Style

Becerra, Á., Soto, F., Vallejos, A., Millán, D., Valenzuela-Fuenzalida, J. J., Leon-Rojas, J. E., & Cortés, M. E. (2026). Bioactive Components of Parthenocissus quinquefolia with Antioxidant and Anti-Inflammatory Properties: A Systematic Review. Antioxidants, 15(2), 169. https://doi.org/10.3390/antiox15020169

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop